Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical relevance of circulating nucleosomes in cancer.
Holdenrieder S, Nagel D, Schalhorn A, Heinemann V, Wilkowski R, von Pawel J, Raith H, Feldmann K, Kremer AE, Müller S, Geiger S, Hamann GF, Seidel D, Stieber P. Holdenrieder S, et al. Among authors: schalhorn a. Ann N Y Acad Sci. 2008 Aug;1137:180-9. doi: 10.1196/annals.1448.012. Ann N Y Acad Sci. 2008. PMID: 18837945 Review.
Circulating nucleosomes in serum.
Holdenrieder S, Stieber P, Bodenmüller H, Busch M, Von Pawel J, Schalhorn A, Nagel D, Seidel D. Holdenrieder S, et al. Among authors: schalhorn a. Ann N Y Acad Sci. 2001 Sep;945:93-102. doi: 10.1111/j.1749-6632.2001.tb03869.x. Ann N Y Acad Sci. 2001. PMID: 11708501 Review.
Apoptosis in serum of patients with solid tumours.
Holdenrieder S, Stieber P, Förg T, Kühl M, Schulz L, Busch M, Schalhorn A, Seidel D. Holdenrieder S, et al. Among authors: schalhorn a. Anticancer Res. 1999 Jul-Aug;19(4A):2721-4. Anticancer Res. 1999. PMID: 10470228
Nucleosomes in serum of patients with benign and malignant diseases.
Holdenrieder S, Stieber P, Bodenmüller H, Busch M, Fertig G, Fürst H, Schalhorn A, Schmeller N, Untch M, Seidel D. Holdenrieder S, et al. Among authors: schalhorn a. Int J Cancer. 2001 Mar 20;95(2):114-20. doi: 10.1002/1097-0215(20010320)95:2<114::aid-ijc1020>3.0.co;2-q. Int J Cancer. 2001. PMID: 11241322 Free article.
[Tumor markers--how they should be applied].
Stieber P, Heinemann V, Schalhorn A. Stieber P, et al. Among authors: schalhorn a. MMW Fortschr Med. 2005 May 19;147(20):35, 37-9. MMW Fortschr Med. 2005. PMID: 15957858 German.
Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer.
Heinemann V, Quietzsch D, Gieseler F, Gonnermann M, Schönekäs H, Rost A, Neuhaus H, Haag C, Clemens M, Heinrich B, Vehling-Kaiser U, Fuchs M, Fleckenstein D, Gesierich W, Uthgenannt D, Einsele H, Holstege A, Hinke A, Schalhorn A, Wilkowski R. Heinemann V, et al. Among authors: schalhorn a. J Clin Oncol. 2006 Aug 20;24(24):3946-52. doi: 10.1200/JCO.2005.05.1490. J Clin Oncol. 2006. PMID: 16921047 Clinical Trial.
105 results